Background: The indications for percutaneous pulmonary valve implantation (PPVI) have been extended to include large dysfunctional right ventricular outflow tracts (RVOTs). Prestenting of the RVOT is commonly performed before PPVI in order to ensure a stable landing zone. The AndraStent XXL (AndraMed GmbH, Reutlingen, Germany), a cobalt-chromium stent with semi-open cell design, has unique mechanical properties in this indication but is no longer available in France.
Aims: To assess the efficiency of AndraStent XXL before PPVI.
Methods: In this retrospective multicentre cohort study, 86 AndraStents XXL were implanted in 77 patients in 6 centres.
Results: PPVI was indicated mainly for pulmonary regurgitation (75.3%) in native or patched RVOT (88.3%). The stents were manually mounted on balloon catheters and delivered through sheaths using a conventional femoral approach. PPVI was performed successfully in 97.4% of patients after successful prestenting, generally during the same procedure (77.9%). There were no deaths associated with stent implantation, and four patients experienced five complications, mainly stent embolization, including one requiring surgery. Neither stent fracture nor dysfunction were observed in any patient during a mean follow-up of 19.2±8.7months. Stent analysis showed an excellent maximal stent expansion (97.1%) regardless of balloon size. A 22.3%±3.4 stent shortening with a 30mm balloon was observed.
Conclusions: Implantation of large cobalt-chromium AndraStent XXL stents is efficient for prestenting before PPVI.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.acvd.2019.12.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Standardized Bench Test Evaluation of Biomechanical Characteristics of Stents Used in Right Ventricular Outflow Tract Revalvulation.
Cardiovasc Eng Technol
August 2024
Nantes Université, CHU Nantes, Service de Cardiologie, l'institut du Thorax, 44000, Nantes, France.
Article Synopsis
- The study investigates the biomechanical properties of five stents used for pre-stenting the right ventricular outflow tract (RVOT) prior to valve implantation.
- Significant findings indicate that while radial and longitudinal elastic recoils are low across all tested stents, there are notable differences in radial resistance and bending stiffness.
- The research proposes an algorithm to aid clinicians in selecting stents based on their required radial force and flexibility, especially in varying vessel conditions.
Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve.
Catheter Cardiovasc Interv
January 2022
Pediatric Cardiology, Gregorio Marañon General University Hospital, Madrid, Spain.
Pulmonary percutaneous valve implantation (PPVI) is feasible with satisfactory mid-term results in patients with native right ventricular outflow tract (RVOT) and has been increasingly used instead of surgically implantable pulmonary valves. Creating a stable landing zone with a diameter less than the largest commercially available valve (previously available 29 mm and currently available 32 mm) is crucial for technical success of the procedure, limiting the number of suitable candidates for PPVI. We report the case of PPVI with a 32 mm Myval transcatheter heart valve in a patient with a large native RVOT (pre-stented with AndraStent XXL mounted on a 35 × 60 mm valve balloon catheter) lesion who had Tetralogy of Fallot surgically corrected.
View Article and Find Full Text PDFRight ventricular outflow tract prestenting with AndraStent XXL before percutaneous pulmonary valve implantation.
Arch Cardiovasc Dis
February 2020
Pôle des cardiopathies congénitales de l'enfant et de l'adulte, centre de référence malformations cardiaques congénitales complexes (M3C), hôpital Marie-Lannelongue, université Paris-Sud, université Paris-Saclay, 133, avenue de la Résistance, 92350 Le Plessis-Robinson, France.
Background: The indications for percutaneous pulmonary valve implantation (PPVI) have been extended to include large dysfunctional right ventricular outflow tracts (RVOTs). Prestenting of the RVOT is commonly performed before PPVI in order to ensure a stable landing zone. The AndraStent XXL (AndraMed GmbH, Reutlingen, Germany), a cobalt-chromium stent with semi-open cell design, has unique mechanical properties in this indication but is no longer available in France.
View Article and Find Full Text PDFNative aortic coarctation stenting in patients ≥ 46 years old.
Postepy Kardiol Interwencyjnej
November 2017
Department of Congenital Heart Diseases and Pediatric Cardiology, Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland.
Introduction: Stent implantation is an effective therapy for aortic coarctation (CoA) in adolescents and adults.
Aim: To present a unique group of patients with native coarctation of the aorta older than or equal to 46 years treated with bare metal or covered stents.
Material And Methods: Since 2002 we have performed stent implantations by applying bare metal stents or covered stents using femoral access in 24 patients aged 46 and older.
Right ventricle outflow tract prestenting: In vitro testing of rigidity and corrosion properties.
Catheter Cardiovasc Interv
February 2018
Pediatric and Congenital Cardiology, UZ Leuven, Leuven, Belgium.
Background: The aim of this study was to assess the resistance to compression (stiffness) of frequently used stents for right ventricular outflow tract prestenting. In addition, to assess the corrosion potential when different types of stent alloys come into contact with each other.
Method: Different stents were tested in vitro in various combinations at specialized metallurgic laboratories.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!